To substantiate this finding, we found that promoter methylation levels increase from non-cancerous prostate tissues to HGPIN to PCa, inversely correlating with transcript levels, thus, indicating a role for EFEMP1 expression perturbation in prostate carcinogenesis. This evidence concerns the gene EFEMP1 and posterior cortical atrophy.